
You refuse to compromise.
We couldn't agree more.

You refuse to compromise.
We couldn't agree more.
Edwards Lifesciences at PCR London Valves 2022
1
Sunday 27 November - 17:30-19:00 (UK time) - Main Arena
Therapy of valvular heart diseases: a patient-centred innovation journey
Join this program if you want:
- To explore how patients have historically been at the centre of technological development for the unmet needs of treating valvular heart disease
- To discuss how innovations enable increasingly sophisticated treatment options that an interdisciplinary heart team can tailor to the needs of each patient against the background of a comprehensive lifetime management
- To deliberate the therapeutic options that are available for patients with progressive or multivalvular heart diseases
Speakers

Prof. Bernard Prendergast
St Thomas' Hospital – London, United Kingdom
Anchorperson
St Thomas' Hospital – London, United Kingdom
Anchorperson

Prof. Joerg Kempfert
German Heart Centre – Berlin, Germany
Moderator
German Heart Centre – Berlin, Germany
Moderator

Dr. Philippe Genereux
Morristown Medical Center’s – New York, USA
Chatmaster
Morristown Medical Center’s – New York, USA
Chatmaster

Dr. Victoria Delgado
University Hospital Germans Trias i Pujol - Barcelona, Spain
Procedural analyst
University Hospital Germans Trias i Pujol - Barcelona, Spain
Procedural analyst

Prof. Augusto D’Onofrio
University Hospital of Padua - Italy
First speaker
University Hospital of Padua - Italy
First speaker

Prof. Helene Eltchaninoff
University Hospital of Rouen - France
Second speaker
University Hospital of Rouen - France
Second speaker

Prof. Fabien Praz
Bern University Hospital - Switzerland
Third speaker
Bern University Hospital - Switzerland
Third speaker
2
Tuesday 29 November - 11:05-12:35 (UK time) - Room 2
TAVI-in-TAVI - A road map for successful lifetime management
Join this program if you want:
- To learn that the choice of the first TAVI is crucial when planning the lifetime management of a patient as it has a significant impact on treatment options in the future
- To understand the challenges that make re-do TAVI so special (so different from TAVI in surgical aortic valve replacement or in native aortic stenosis)
- To familiarise with a strategy that guides operators through different technical scenarios for the best possible outcomes
Speakers

Prof. Hendrik Treede
Heart and Vascular Center - Mainz, Germany
Anchorperson
Heart and Vascular Center - Mainz, Germany
Anchorperson

Dr. Daniel Blackman
Yorkshire Heart Centre
Moderator
Yorkshire Heart Centre
Moderator

Dr. Victoria Delgado
University Hospital Germans Trias i Pujol - Barcelona, Spain
Chatmaster
University Hospital Germans Trias i Pujol - Barcelona, Spain
Chatmaster

Prof. Giuseppe Tarantini
University Hospital of Padua – Padova, Italy
First speaker
University Hospital of Padua – Padova, Italy
First speaker

Dr. Janarthanan Sathananthan
Vancouver General and St Paul’s
Second speaker
Vancouver General and St Paul’s
Second speaker

Dr. Francesco Saia
University Hospital of Bologna
Third speaker
University Hospital of Bologna
Third speaker

Dr. Radoslaw Parma
Medical University of Silesia – Katowice, Poland
Fourth speaker
Medical University of Silesia – Katowice, Poland
Fourth speaker

Prof. Ole de Backer
Rigshospitalet, Copenhagen
Fifth speaker
Rigshospitalet, Copenhagen
Fifth speaker
Sign up now to receive copies of Edwards Lifesciences recorded event sessions post event, as well as receive event and news informations from Edwards Lifesciences, including:
Publications
Panel discussions
Conference headlines
Guidelines updates
Thank You
Thank you for signing up to the heartvalves.com newsletter. You will now receive emails on the latest developments and industry insights in heart valve innovation and technology.
Back to homeMedical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
PP--EU-5445 v1.0